Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: Intracerebral haemorrhage (ICH) survivors are at increased risk of major adverse cardiovascular and cerebrovascular events (MACE) compared to population controls; however, little is known about the annual rates and risk factors for MACE. METHODS: We systematically searched Medline, Embase, and trial registries in April 2024 for studies of adults with ICH reporting either a MACE outcome or both ischaemic and haemorrhagic outcomes with at least one year of follow-up. We excluded studies limited to secondary ICH or other isolated non-ICH intracranial haemorrhages. We used QUIPS tool to assess studies' risk of bias. The primary outcome was the rate of MACE. We used a random-effects meta-analysis ('metarate' in R) to estimate the annual event rate (per 100 person-years, expressed as %) for each outcome. We conducted subgroup analyses and meta-regression to explore heterogeneityResults:We included 26 studies, involving 198,289 ICH survivors. Individual studies' reported annual rate of MACE ranged from 4.2-14.6%. The pooled annual rate of recurrent ICH was 2.1% (95% CI 1.7-2.6; 26 studies; I2=94%) and of ischaemic stroke was 2.0% (95% CI 1.5-2.7; 24 studies; I2=95%). In the meta-regression analysis, only a higher prevalence of atrial fibrillation was associated with an increased risk of ischaemic stroke. DISCUSSION: The rates of recurrent ICH and ischaemic stroke were comparable among ICH survivors, but evidence on the other MACE outcomes remains limited. An individual participant data meta-analysis is needed to investigate the predictors of MACE outcomes, which may help inform risk stratification and prognosis among ICH survivors.

More information Original publication

DOI

10.1177/17474930261416692

Type

Journal article

Publication Date

2026-01-28T00:00:00+00:00

Keywords

MACE, Stroke, intracererbal haemorrhage, prognosis, stroke recurrence, systematic review